Decades-Old Drug May Offer First Real Hope for Ultra-Rare, Life-Threatening Genetic Disorder - SciTechDaily
Google News • 1/15/2026 – 1/16/2026
Summary
Scientists are exploring the potential of a decades-old drug, DFMO, to treat Bachmann–Bupp Syndrome, an ultra-rare and life-threatening genetic disorder. A collaboration involving Michigan State University and David Fajgenbaum has led to the launch of the DFMO repurposing program aimed at advancing its use for more patients.
Advertisement
Lindy Score Breakdown (V4.2)
51d
Age
1
Sources
from cluster
1187
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1187/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1187/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (6/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 51 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: A drug company with a side of gold?
Stat News • 1 day ago
Across ERs, Tylenol orders for pregnant people dropped after health officials linked drug to autism
Stat News • 1 day ago
Opinion: Obesity drugs may silence the ‘drug noise’ behind all addiction
Stat News • 2 days ago
STAT+: Gilead and South Africa are negotiating a license for local production of new HIV drug
Stat News • 1 day ago
STAT+: Eli Lilly launches program for employers to subsidize cost of obesity drug outside insurance
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about an FDA-UniQure tussle, a Pfizer obesity drug approval in China, and more
Stat News • Today
STAT+: Servier to acquire Day One, maker of pediatric cancer drug, for $2.5B
Stat News • Today
STAT+: UnitedHealth promised transparency. Instead, it’s cutting back key disclosures
Stat News • 2 days ago
Breaching the IBD efficacy ceiling, and sham surgeries
Stat News • 1 day ago
Pediatric nicotine exposure shifts with trends
Stat News • 1 day ago